4.1 Hypertrophic and Restrictive Cardiomyopathy in Children

4.1 Hypertrophic and Restrictive Cardiomyopathy in Children

Clinical Core: Pediatric cardiomyopathies encompass a diverse spectrum of primary myocardial disorders characterized by mechanical, electrical, or structural dysfunction. While congenital structural malformations dominate pediatric cardiology, cardiomyopathies represent the leading indication for pediatric cardiac transplantation beyond infancy. Hypertrophic cardiomyopathy (HCM) and restrictive cardiomyopathy (RCM) represent contrasting morphological and hemodynamic paradigms: HCM features marked non-dilated myocardial hypertrophy with preserved or hyperdynamic systolic function and potential dynamic outflow tract obstruction, whereas RCM is defined by extreme diastolic ventricular non-compliance and elevated filling pressures occurring within non-hypertrophied, non-dilated ventricles.

---

Hypertrophic Cardiomyopathy (HCM): Definition & Somatic Sizing

Hypertrophic cardiomyopathy accounts for approximately 35% to 40% of all pediatric cardiomyopathy cases, representing the second most common entity after dilated cardiomyopathy. It is defined as unexplained, non-dilated left ventricular (or biventricular) hypertrophy occurring in one or more myocardial segments that cannot be accounted for solely by abnormal loading conditions (such as valvar aortic stenosis, coarctation of the aorta, or systemic arterial hypertension).

Pediatric BSA-Adjusted Z-Scores vs. Adult Fixed Cutoffs

In adult clinical practice, an absolute maximal diastolic wall thickness $\ge 15$ mm (or $\ge 13$ mm with an established family history) satisfies diagnostic criteria. In pediatric echocardiography, absolute millimeter cutoffs are entirely invalid because children undergo dramatic somatic growth from neonates to young adults:

$\text{LV Wall Thickness Z-score} > +2.0$

• Diagnostic Threshold: A maximal end-diastolic wall thickness with a body surface area (BSA)-adjusted Z-score > +2.0 (exceeding two standard deviations above the population mean for somatic size) establishes the presence of pathological hypertrophy.
• Extreme / Massive Hypertrophy Threshold: A maximal wall thickness Z-score $\ge +6.0$ (or absolute thickness $\ge 30$ mm in fully grown adolescents) defines extreme hypertrophy and serves as a major, independent risk factor for sudden cardiac death.

Normal Pediatric Septum (Z = 0)  -->  Z-score +2.0 (Threshold for Pathologic Hypertrophy)
                                                 │
                                                 ▼
                                      Z-score ≥ +6.0 (Massive Hypertrophy / High SCD Risk)

---

Sarcomeric Genetics & High-Yield Syndromic / Metabolic Phenocopies

In children, the clinical and genetic landscape of hypertrophic cardiomyopathy bifurcates sharply according to age of presentation:

• In older children and adolescents (>1–2 years of age), the overwhelming majority represent true familial sarcomeric HCM.
• In neonates and infants (<1 year of age), true sarcomeric disease is less frequent; the majority of hypertrophic presentations represent syndromic, metabolic, or maternal phenocopies.

1. Familial Sarcomeric HCM

Transmitted predominantly as an autosomal dominant trait with incomplete penetrance and variable age-dependent expressivity:

• MYH7 (Beta-myosin heavy chain): Accounts for ~40% of genotyped pediatric cases; characteristically associated with earlier clinical onset, more extensive septal hypertrophy, and higher incidence of malignant ventricular arrhythmias.
• MYBPC3 (Cardiac myosin-binding protein C): Accounts for ~30% to 40% of cases; historically viewed as an adolescent- or adult-onset variant, but can present in childhood with progressive septal thickening.
• TNNT2 (Cardiac troponin T) & TNNI3 (Cardiac troponin I): Sarcomeric thin-filament variants; associated with significant arrhythmia risk and sudden death, occasionally even in the presence of mild or borderline structural hypertrophy.

2. High-Yield Syndromic & Metabolic Phenocopies

---

Morphological Subtypes & Quantitative Measurement Principles

Morphological Variants in Pediatric HCM

1. Asymmetric Septal Hypertrophy (ASH): The predominant morphological presentation, accounting for >70% of pediatric cases. Hypertrophy involves primarily the basal and mid-anterior interventricular septum, sparing the posterior free wall. Defined quantitatively as an interventricular septal to left ventricular posterior wall ratio (IVS/LVPW) > 1.3 in children (>1.5 in adolescents).
2. Concentric Hypertrophy: Uniform, circumferential thickening involving all left ventricular segments with progressive end-systolic cavity obliteration. Strongly indicates an underlying metabolic storage disorder (Pompe disease, Danon disease) or mitochondrial cytopathy.
3. Apical HCM (Yamaguchi Variant): Hypertrophy localized primarily to the LV apex distal to the papillary muscles, creating a classic "ace-of-spades" end-systolic cavity silhouette on the apical four-chamber view. Less common in young children; typically emerges in adolescence.
4. Mid-Ventricular Hypertrophy: Concentric muscular thickening at the level of the papillary muscles, creating a dumbbell-shaped LV cavity with mid-cavity dynamic systolic pressure gradients and predisposing to apical aneurysm formation.

Normal Geometry:         Asymmetric Septal (ASH):     Concentric (Pompe/Storage):    Apical (Yamaguchi):
  ┌─────────┐              ┌────█████┐                   ┌──███████┐                     ┌─────────┐
  │         │              │    █████│                   │█       █│                     │         │
  │   LV    │              │ LV  ████│                   │█  LV   █│                     │   LV    │
  │         │              │     ████│                   │█       █│                     │   ███   │
  └─────────┘              └─────────┘                   └──███████┘                     └─███████─┘
(IVS/LVPW ~ 1.0)         (IVS/LVPW > 1.3)             (All walls thickened)           ("Ace-of-Spades")

Sonographic Technique & Diagnostic Pitfalls

• Measurements must be obtained from high-frame-rate 2D cine loops or 2D-directed M-mode in the parasternal short-axis view at the mitral chordal level at end-diastole (onset of the QRS complex).
• The measurement caliper must be positioned perpendicular to the myocardial wall.
• The Moderator Band & False Tendon Pitfall: A prominent right ventricular moderator band inserting high on the right side of the septum, hypertrophied RV trabeculations, or false tendons traversing the LV cavity will artificially exaggerate septal thickness if included within the caliper, generating false-positive Z-scores. Always confirm that calipers encompass only true, compact myocardium.

---

Dynamic LVOT Obstruction (LVOTO) & Mitral Valve Mechanics

Dynamic left ventricular outflow tract obstruction is identified in approximately 30% of pediatric HCM patients at rest, with another 30% to 40% demonstrating latent, provocable obstruction during physiological stress (exercise, crying, Valsalva maneuver, or catecholamine administration).

Hypertrophied Basal Septum + Displaced Papillary Muscles
                     │
                     ▼
        Narrowed Anatomical Outflow Tract
                     │
                     ▼
 Accelerated Flow Velocity ──► Aerodynamic Drag & Venturi Suction
                                            │
                                            ▼
                           Systolic Anterior Motion (SAM)
                           (Mitral Leaflet Contacts Septum)
                                            │
                    ┌───────────────────────┴───────────────────────┐
                    ▼                                               ▼
        Dynamic Subaortic Obstruction                  Incomplete Mitral Coaptation
        (Mid-systolic flow deceleration)                            │
                    │                                               ▼
                    ▼                                  Posterolaterally Directed
    Late-Peaking "Dagger-Shaped" CW Doppler              Eccentric Regurgitant Jet
    (Aortic Valve Mid-Systolic Closure Notch)

The Pathophysiological Triad of Dynamic LVOTO

1. Systolic Anterior Motion (SAM) of the Mitral Valve: In pediatric HCM, the mitral valve apparatus is frequently abnormal: the anterior mitral leaflet is elongated, and the papillary muscles are displaced anteriorly and medially. During mid-systole, high-velocity blood entering the narrowed LVOT generates aerodynamic drag and Venturi suction forces that draw the distal anterior mitral leaflet tip anteriorly into the outflow tract, resulting in direct contact with the hypertrophied septum.
2. Aortic Valve M-Mode Hallmarks: The abrupt mid-systolic pressure drop distal to the SAM obstruction produces pathognomonic mid-systolic partial closure (notching or fluttering) of the aortic valve leaflets, followed by late-systolic reopening.
3. Continuous-Wave (CW) Spectral Doppler Characteristics:
   • Fixed subaortic or valvular aortic stenosis exhibits a symmetric, parabolic (bullet-shaped) velocity envelope peaking in early-to-mid systole.
   • In contrast, dynamic LVOTO generates a distinct late-peaking, concave-upward, 'dagger-shaped' or 'saber-shaped' continuous-wave Doppler envelope, reflecting progressive acceleration that reaches maximal velocity in late systole.
   • A peak instantaneous pressure gradient $\ge 30$ mmHg at rest defines dynamic obstruction; a gradient $\ge 50$ mmHg denotes severe, hemodynamically significant obstruction.
4. Eccentric Secondary Mitral Regurgitation: Because SAM pulls the anterior leaflet away from the posterior leaflet during mid-systole, coaptation is disrupted. This produces an eccentric, posterolaterally directed mitral regurgitation jet that begins in mid-systole. An anteriorly or centrally directed jet indicates intrinsic structural mitral valve disease (such as cleft leaflet or prolapse) rather than isolated SAM.

---

Pediatric Sudden Cardiac Death (SCD) Risk Stratification

Sudden cardiac death is the most devastating complication of pediatric HCM, with an annual mortality rate of approximately 1% to 2%. Adult risk calculators underestimate pediatric risk. In children, comprehensive risk stratification incorporates validated multivariable scoring tools (such as the HCM Risk-Kids model):

Primary High-Risk Markers for ICD Placement

1. Massive Left Ventricular Hypertrophy: Maximal wall thickness Z-score $\ge +6.0$ (or absolute wall thickness $\ge 30$ mm in mature adolescents).
2. Unexplained Exertional Syncope: Recent, non-vasovagal syncope occurring during or immediately following physical exertion within the prior 6 to 12 months.
3. Documented Non-Sustained Ventricular Tachycardia (NSVT): Repetitive runs of $\ge 3$ consecutive ventricular beats at a rate $\ge 120$ bpm on 24- to 48-hour ambulatory Holter monitoring.
4. Family History of Premature Sudden Cardiac Death: Sudden cardiac arrest or death in one or more first-degree relatives under 40 years of age, or in any relative with confirmed HCM.
5. Extensive Late Gadolinium Enhancement (LGE) on CMR: Myocardial fibrosis involving $>15%$ of total LV myocardial mass, reflecting severe myocyte disarray and replacement collagen deposition.
6. Blunted Blood Pressure Response to Exercise: Failure of systolic blood pressure to increase by $\ge 20$ to 25 mmHg during peak treadmill or cycle exercise testing.
7. Resting Dynamic LVOTO Gradient: Resting peak instantaneous outflow gradient $\ge 30$ to 50 mmHg.

---

Restrictive Cardiomyopathy (RCM): Pathophysiology & Chamber Morphology

Restrictive cardiomyopathy is the rarest form of cardiomyopathy in children, accounting for less than 5% of all pediatric cardiomyopathy diagnoses. Despite its rarity, it carries the worst natural history and highest mortality of any childhood cardiomyopathy: approximately 50% of affected children die or require cardiac transplantation within 2 years of diagnosis, primarily due to rapid progression of pulmonary arterial hypertension, congestive heart failure, or sudden cardiac death.

Pathophysiological Foundation

RCM is characterized by increased myocardial stiffness and severe impairment of ventricular diastolic relaxation and compliance. Ventricular filling pressures rise precipitously with minimal volume increments, while left and right ventricular systolic contractile performance is typically preserved until end-stage disease.

Etiologies in Pediatric RCM

• Familial Sarcomeric Mutations (>50%): De novo dominant or inherited mutations in cardiac sarcomeric genes, most frequently TNNI3 (cardiac troponin I), followed by TNNT2, ACTC1, and MYH7. A single missense mutation in TNNI3 can produce severe restrictive pathophysiology with minimal structural hypertrophy.
• Inborn Errors of Metabolism & Storage: Fabry disease (late stage), Gaucher disease, and Pompe disease. Amyloidosis, a leading cause of adult RCM, is exceptionally rare in the pediatric age group.
• Idiopathic & Secondary Fibrosis: Post-mediastinal radiation, prior anthracycline toxicity, or endomyocardial fibroelastosis (EFE).

Classical Anatomical Hallmarks

• Massive Biatrial Enlargement: The cardinal morphological finding in pediatric RCM is extreme, symmetric dilation of both the left atrium and the right atrium (often referred to as the 'snowman' or 'Mickey Mouse' sign).
• Normal or Diminutive Ventricles: Concurrently, both left and right ventricular cavity dimensions, wall thicknesses, and systolic ejection fractions are completely normal or small.

---

Diastolic Spectral & Tissue Doppler Hemodynamics in RCM

Because systolic function is preserved, echocardiographic diagnosis and hemodynamic staging of RCM depend entirely on spectral and tissue Doppler interrogation of ventricular filling dynamics:

Normal Mitral Inflow:                Restrictive Mitral Inflow (RCM):

 Velocity                             Velocity
   ▲      E                             ▲      E (Tall, Narrow)
   │    ┌───┐                           │    ┌───┐
   │    │   │      A                    │    │   │
   │    │   │    ┌───┐                  │    │   │
   │    │   │    │   │                  │    │   │      A (Diminutive)
   └───┴───┴────┴───┴───── Baseline     └───┴───┴────┌───┐─── Baseline
      E/A ~ 1.2 - 1.8, DT > 150 ms          E/A > 2.0 - 3.5, DT < 120 - 140 ms

1. Mitral Inflow Spectral Doppler

• Tall E Wave & Diminutive A Wave: Markedly increased early diastolic filling velocity ($E$) driven by high left atrial driving pressure, with an abbreviated late filling velocity ($A$) due to elevated end-diastolic ventricular pressure arresting late filling.
• Restrictive E/A Ratio > 2.0: Frequently exceeding 2.5 to 3.5 in symptomatic children.
• Shortened Deceleration Time (DT < 140 ms): Typically <120 ms, reflecting rapid early filling that is abruptly halted by non-compliant, rigid ventricular walls.
• Shortened Isovolumic Relaxation Time (IVRT < 50–60 ms).

2. Tissue Doppler Imaging (TDI) & E/e' Ratio

• Profoundly Depressed Annular Velocities: Medial and lateral early diastolic mitral annular velocities are severely depressed ($e' < 5\text{--}6$ cm/s; normal pediatric $e'$ is 10–16 cm/s), proving intrinsic myocardial relaxation failure.
• Elevated E/e' Ratio > 14 to 15: Strongly correlates with markedly elevated left ventricular end-diastolic pressure (LVEDP) and pulmonary capillary wedge pressure (PCWP).

3. Pulmonary Venous Spectral Doppler Profile

• Systolic Blunting: Systolic forward flow is blunted or reversed ($S < D$ pattern).
• Prolonged Atrial Reversal (Ar Wave): During atrial systole, blood preferentially decompresses retrogradely into the pulmonary veins rather than entering the stiff ventricle. An Ar wave duration exceeding the transmitral A wave duration by $>30$ ms (and peak velocity $>0.35$ m/s) is diagnostic of elevated LVEDP.

4. Rapid Progression to Pulmonary Arterial Hypertension (PAH)

Chronic backward transmission of severely elevated left atrial pressure into the pulmonary venous circulation triggers reactive pulmonary arterial vasoconstriction and vascular remodeling. Children with RCM develop aggressive pulmonary hypertension with tricuspid regurgitant jet velocities exceeding 3.5 to 4.5 m/s, leading to secondary right ventricular hypertrophy and biventricular failure.

---

Differential Diagnosis: RCM vs. Constrictive Pericarditis vs. DCM

Differentiating restrictive cardiomyopathy from constrictive pericarditis (CP) is one of the most critical diagnostic challenges in cardiology. Both present with signs of severe right- and left-sided venous congestion, preserved systolic function, and normal ventricular cavity sizes. However, constrictive pericarditis is surgically treatable via pericardiectomy, whereas restrictive cardiomyopathy carries a dismal prognosis requiring early cardiac transplantation.

Diagnostic Comparison: Pediatric Cardiomyopathies & Constriction

---

Clinical Pearls & Sonographic Traps

[!WARNING] The Infant Diastolic Doppler Trap: Normal neonates and infants naturally exhibit rapid resting heart rates (120–160 bpm) and compliant left atria, often displaying E/A ratios between 1.2 and 1.6 with physiological deceleration times between 110 and 140 ms. Never diagnose restrictive cardiomyopathy based solely on mitral inflow velocities in an infant! A valid RCM diagnosis mandates demonstration of massive biatrial enlargement, elevated E/e' ratio (>14–15), and abnormally depressed TDI e' velocities (<5–6 cm/s).

[!IMPORTANT] The Annulus Paradoxus Mechanism: In normal myocardium and in RCM, the lateral mitral annulus moves with greater longitudinal velocity than the medial annulus ($e'{\text{lateral}} > e'{\text{medial}}$). In constrictive pericarditis, the rigid, calcified pericardium adheres to and restricts the adjacent lateral LV free wall, while the central fibrous skeleton is relatively spared. Consequently, the medial annulus velocity is preserved or augmented while lateral velocity is suppressed (medial $e' >$ lateral $e'$; termed annulus reversus). Finding a medial $e' > 8\text{--}10$ cm/s strongly rules out restrictive cardiomyopathy.

[!TIP] Preventing Overestimation of Septal Thickness in HCM: When measuring the interventricular septum, never measure at the basal hinge point of the aortic valve where physiological fibrous thickening occurs. Always measure in the parasternal short-axis view at the chordal level, perpendicular to the myocardial borders, and carefully sweep to ensure the caliper does not include RV moderator bands or false tendons.